Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 47 resources
-
NICE Quality Standard on Liver Disease
This NICE quality standard covers identifying, assessing and managing chronic liver disease in children, young people and adults, and cirrhosis in young people and adults. It describes high-quality care in priority areas for improvement.UK, England Jun 2017 Other, Strategy & Planning PDF -
Hepatitis C scare stories: true or false
Produced by Sheffield Teaching Hospitals NHS Foundation Trust, this resource is a series of posters which address common perceptions of hepatitis C, dispelling myths and providing facts about the virus.UK Other, Tools & Templates PDF -
HCV Action and PHE hepatitis C roadshow in Cambridge: Presentations
On 9th May 2017, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Cambridge. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Cambridge and the wider east of England region.UK, England, East of England Other, Strategy & Planning PDF -
Guidelines on hepatitis B and C testing
These are the first WHO guidelines on testing for chronic hepatitis B and C infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for hepatitis B and C, and are intended for use across age groups and populations.Rest of World Feb 2017 Other, Strategy & Planning PDF -
National Clinical Guidelines for the treatment of HCV in adults
These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.Scotland Jan 2017 Other, Strategy & Planning PDF -
HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.UK, England, North West Other, Strategy & Planning PDF -
Pathways Coordinator Q&A
Andy Pearson, The Hepatitis C Trust’s Pathways Coordinator, explains the role and the importance of testing and referral pathways for hepatitis C in substance misuse services.UK Other, Training PDF -
EASL Recommendations on Treatment of Hepatitis C 2016
These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.Rest of World Sep 2016 Other, Reports & Research PDF -
HCV Action and PHE hepatitis C roadshow in Newcastle: Presentations
On 17th May 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Newcastle. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Newcastle and the wider north east region.North East, UK, England Jun 2016 Other, Strategy & Planning PDF -
WHO Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection
These guidelines, developed by the World Health Organisation, promote the transition to newer, more effective medicines that have the potential to cure most persons living with hepatitis C infection. They also provide guidance on which specific regimens should be used based on a patient’s clinical history as well as genotype, and are intended to promote the scale-up of hepatitis C treatment.UK, Rest of World Apr 2016 Other, Strategy & Planning PDF